Genetic susceptibility to Hodgkin's lymphoma associated with the human leukocyte antigen region
暂无分享,去创建一个
G. T. te Meerman | A. Diepstra | S. Poppema | T. Meerman | M. Niens | A. Diepstra | G. J. Te Meerman | S. Poppema | A. Berg | M. Niens | A. Berg | A. Berg
[1] A. Rickinson,et al. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. , 1997, Journal of immunology.
[2] A. Videbaek. Familial Hodgkin's disease. , 1955, Acta haematologica.
[3] J. Goedert,et al. Spectrum of AIDS-associated malignant disorders , 1998, The Lancet.
[4] D. Motto,et al. ADAMTS13 Binds VWF Via its C-Terminal CUB2 Domain. , 2004 .
[5] C Dosne Pasqualini,et al. The HLA system. , 1979, Medicina.
[6] J. Dausset,et al. HLA and Susceptibility to Hodgkin's Disease , 1983, Immunological reviews.
[7] A. van den Berg,et al. Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] E. Bloemena,et al. Identification and prevalence of CD8+ T‐cell responses directed against Epstein‐Barr virus‐encoded latent membrane protein 1 and latent membrane protein 2 , 2002, International journal of cancer.
[9] P. Boffetta,et al. Familial Hodgkin's disease: a disease of young adulthood? , 1997, Annals of Hematology.
[10] A. van den Berg,et al. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. , 1999, The American journal of pathology.
[11] F. Herrmann,et al. Hodgkin's disease: a tumor with disturbed immunological pathways. , 1997, Immunology today.
[12] Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. , 1999, Nature.
[13] R. Jarrett. Viruses and Hodgkin's lymphoma. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] T. Landberg,et al. HLA antigens in Hodgkin's disease of very long survival. , 1978, Acta radiologica: oncology, radiation, physics, biology.
[15] S. Pileri,et al. Expression of B-Cell Markers in Classical Hodgkin Lymphoma: A Tissue Microarray Analysis of 330 Cases , 2003, Modern Pathology.
[16] W. Klitz,et al. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. , 1992, Journal of immunology.
[17] S. Hsu,et al. The nature of Reed-Sternberg cells: phenotype, genotype, and other properties. , 1994, Critical reviews in oncogenesis.
[18] Y. Shugart,et al. A genetic study of Hodgkin's lymphoma: an estimate of heritability and anticipation based on the familial cancer database in Sweden , 2000, Human Genetics.
[19] W. Blattner,et al. HLA antigens in familial Hodgkin's disease , 1979, International journal of cancer.
[20] Jose M Garcia,et al. Simultaneous Hodgkin's disease in three siblings with identical HLA‐genotype , 1980, Cancer.
[21] K. Karube,et al. Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: Classical Hodgkin lymphoma vs. Hodgkin‐like ATLL , 2003, International journal of cancer.
[22] D. Osoba,et al. The prognostic value of HLA phenotypes in Hodgkin's disease , 1980, Cancer.
[23] P. Murray,et al. Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition. , 1998, Blood.
[24] A. van den Berg,et al. Immune reactions in classical Hodgkin's lymphoma. , 1999, Seminars in hematology.
[25] J. Dausset,et al. HLA genotypes in familial Hodgkin's disease. Excess of HLA identical affected subs. , 1980, European journal of cancer.
[26] G. M. Taylor,et al. Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype-associated. , 1996, Leukemia.
[27] S. Bigner,et al. Familial Hodgkin's disease a clinical and laboratory investigation , 1987, Cancer.
[28] T. Lister,et al. Association of HLA-DPB with Hodgkin's disease , 1992, The Lancet.
[29] H. Heslop,et al. Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells. , 2002, Cancer research.
[30] L. Young,et al. Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease. , 1998, Blood.
[31] E. Perlin,et al. Another Observation of Increased Frequency of HL-A 5 and HL-A 8 in Hodgkin’s Disease , 1975 .
[32] B. Nathwani,et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. , 1995, The New England journal of medicine.
[33] T. Lister,et al. A clinical and epidemiological study of human leukocyte antigen-DPB alleles in Hodgkin's disease. , 1994, Cancer research.
[34] M. Carrington,et al. HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease. , 2002, Blood.
[35] C. A. Doan,et al. Studies in Hodgkin's syndrome. XII. Hereditary and epidemiologic espects. , 1957, Annals of internal medicine.
[36] M. Björkholm,et al. A prospective study of HL-A antigen phenotypes and lymphocyte abnormalities in Hodgkin's disease. , 2008, Tissue antigens.
[37] G. M. Taylor,et al. Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes , 1999, British Journal of Cancer.
[38] P. Brousset,et al. Epstein‐Barr virus‐associated Hodgkin's disease: Epidemiologic characteristics in international data , 1997, International journal of cancer.
[39] J. Lukens,et al. Hodgkin's disease in three children from an Amish kindred. , 1972, The Journal of pediatrics.
[40] T. Lister,et al. HLA-DP BASED RESISTANCE TO HODGKIN'S DISEASE , 1989, The Lancet.
[41] T. Mak,et al. The role of cytokines in classical Hodgkin lymphoma. , 2002, Blood.
[42] W. Klitz,et al. Localization of predisposition to Hodgkin disease in the HLA class II region. , 1994, American journal of human genetics.
[43] S. Grufferman,et al. Clustering and aggregation of exposures in Hodgkin's disease , 1977, Cancer.
[44] A. Chakravarti,et al. Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance , 1986, Genetic epidemiology.
[45] Gen Tamiya,et al. Complete sequence and gene map of a human major histocompatibility complex , 1999 .
[46] S. Glaser,et al. Hodgkin's disease in Asians: incidence patterns and risk factors in population-based data. , 2002, Leukemia research.
[47] M. King,et al. Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method. , 1983, Human immunology.
[48] J. Barnard,et al. Hla in familial hodgkin's disease. Results and a new hypothesis , 1977, International journal of cancer.
[49] Nawal M. El‐Kholy,et al. The value of HLA phenotypes in the prognosis of Hodgkin's lymphoma , 1985, International journal of cancer.
[50] E. Creagan,et al. Familial Hodgkin's disease. , 1972, Lancet.
[51] J. Hansen,et al. HLA and MLC typing in patients with Hodgkin's disease. , 1977, Progress in clinical and biological research.
[52] L. Craver,et al. Familial Hodgkin's disease: its significance and implications. , 1959, Annals of internal medicine.
[53] L. Liau,et al. Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done , 2004 .
[54] A. Berg. Immune dysfunction in classical Hodgkin lymphoma. , 2004 .
[55] R. Conte,et al. HLA IN FAMILIAL HODGKIN'S DISEASE , 1983, Journal of immunogenetics.
[56] Rong Wang,et al. The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity. , 2001, Trends in immunology.
[57] J. Klein,et al. The HLA system. First of two parts. , 2000, The New England journal of medicine.
[58] J. Baak,et al. Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxic T-cell response in Epstein-Barr virus-positive and -negative Hodgkin's disease. , 1996, Blood.
[59] G. M. Taylor,et al. Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve). , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.